Increased PD-L1 surface expression on peripheral blood granulocytes and monocytes after vaccination with SARS-CoV2 mRNA or vector vaccine

Clin Chem Lab Med. 2022 Oct 18;61(1):e17-e19. doi: 10.1515/cclm-2022-0787. Print 2023 Jan 27.

Authors

Lorin Loacker¹, Janine Kimpel², Zoltán Bánki², Christoph Q Schmidt³, Andrea Griesmacher¹, Markus Anliker¹

Affiliations

¹ Central Institute for Medical and Chemical Laboratory Diagnosis, University Hospital, Innsbruck, Austria.
² Department of Hygiene, Microbiology and Public Health, Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
³ Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm, Germany.

PMID: 36245120
DOI: 10.1515/cclm-2022-0787

No abstract available

Keywords: SARS-CoV-2; immune checkpoint; programmed death-ligand 1 (PD-L1); vaccination.

Publication types

Letter

MeSH terms

B7-H1 Antigen / genetics
B7-H1 Antigen / metabolism
COVID-19* / prevention & control
Granulocytes / metabolism
Humans
Monocytes / metabolism
RNA, Messenger / genetics
RNA, Messenger / metabolism
RNA, Viral / metabolism
SARS-CoV-2
Vaccination
Vaccines* / metabolism

Substances

B7-H1 Antigen
RNA, Viral
RNA, Messenger
Vaccines